Schrag, Deborah

Symptom Monitoring With Patient-Reported Outcomes During Routine Cancer Treatment: A Randomized Controlled Trial

Basch, E., Deal, A. M., Kris, M. G., Scher, H. I., Hudis, C. A., Sabbatini, P., Rogak, L., Bennett, A. V., Dueck, A. C., Atkinson, T. M., et al. (2016) · Journal of Clinical Oncology

Cancer survivorship and careMobile Health and mHealth Applications

Cited by 2,593

Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment

Basch, E., Deal, A. M., Dueck, A. C., Scher, H. I., Kris, M. G., Hudis, C., & Schrag, D. (2017) · JAMA

Cancer survivorship and careMobile Health and mHealth Applications

Cited by 2,302

AACR Project GENIE: Powering Precision Medicine through an International Consortium

The AACR Project GENIE Consortium, The AACR Project GENIE Consortium, André, F., Arnedos, M., Baras, A. S., Baselga, J., Bedard, P. L., Berger, M. F., Bierkens, M., Calvo, F., et al. (2017) · Cancer Discovery

Cancer Genomics and DiagnosticsLung Cancer Treatments and Mutations

Cited by 1,964

Patients’ expectations about effects of chemotherapy for advanced cancer

Weeks, J. C., Catalano, P. J., Cronin, A., Finkelman, M. D., Mack, J. W., Keating, N. L., & Schrag, D. (2012) · New England Journal of Medicine

Patient-Provider Communication in HealthcarePalliative Care and End-of-Life Issues

Cited by 1,149

Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry.

Chung, K. Y., Shia, J., Kemeny, N. E., Shah, M., Schwartz, G. K., Tse, A., Hamilton, A., Pan, D., Schrag, D., Schwartz, L., et al. (2005) · Journal of Clinical Oncology

Colorectal Cancer Treatments and StudiesHER2/EGFR in Cancer Research

Cited by 1,081

Validity and Reliability of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Dueck, A. C., Mendoza, T. R., Mitchell, S. A., Reeve, B. B., Castro, K. M., Rogak, L. J., Atkinson, T. M., Bennett, A. V., Denicoff, A. M., O'Mara, A. M., et al. (2015) · JAMA Oncology

Cancer survivorship and careCancer-related cognitive impairment studies

Cited by 1,030

Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial

Venook, A. P., Niedzwiecki, D., Lenz, H.-J., Innocenti, F., Fruth, B., Meyerhardt, J. A., Schrag, D., Greene, C., O'Neil, B. H., Atkins, J. N., et al. (2017) · JAMA

Colorectal Cancer Treatments and StudiesColorectal Cancer Surgical Treatments

Cited by 898

Analysis and Visualization of Longitudinal Genomic and Clinical Data from the AACR Project GENIE Biopharma Collaborative in cBioPortal

de Bruijn, I., Kundra, R., Mastrogiacomo, B., Tran, T. N., Sikina, L., Mazor, T., Li, X., Ochoa, A., Zhao, G., Lai, B., et al. (2023) · Cancer Research

Cancer Genomics and DiagnosticsBioinformatics and Genomic Networks

Cited by 886

Patient versus clinician symptom reporting using the national cancer institute common terminology criteria for adverse events: results of a questionnaire-based study

Basch, E., Iasonos, A., McDonough, T., Barz, A., Culkin, A., Kris, M. G., Scher, H. I., & Schrag, D. (2006) · The Lancet Oncology

Cancer survivorship and carePharmacovigilance and Adverse Drug Reactions

Cited by 653

Effect of Electronic Symptom Monitoring on Patient-Reported Outcomes Among Patients With Metastatic Cancer: A Randomized Clinical Trial

Basch, E., Schrag, D., Henson, S., Jansen, J., Ginos, B., Stover, A. M., Carr, P., Spears, P. A., Jonsson, M., Deal, A. M., et al. (2022) · JAMA

Cancer survivorship and careMobile Health and mHealth Applications

Cited by 413

Outcomes of prognostic disclosure: associations with prognostic understanding, distress, and relationship with physician among patients with advanced cancer

Enzinger, A. C., Zhang, B., Schrag, D., & Prigerson, H. G. (2015) · Journal of Clinical Oncology

Palliative Care and End-of-Life IssuesPalliative and Oncologic Care

Cited by 379

Clinical utility and user perceptions of a digital system for electronic patient-reported symptom monitoring during routine cancer care: findings from the PRO-TECT trial

Basch, E., Stover, A. M., Schrag, D., Chung, A., Jansen, J., Henson, S., Carr, P., Ginos, B., Deal, A., Spears, P. A., et al. (2020) · JCO Clinical Cancer Informatics

Cancer survivorship and careMobile Health and mHealth Applications

Cited by 194

Automated Real-World Data Integration Improves Cancer Outcome Prediction

Jee, J., Fong, C., Pichotta, K., Tran, T. N., Luthra, A., Waters, M., Fu, C., Altoe, M., Liu, S.-Y., Maron, S. B., et al. (2024) · Nature

Machine Learning in HealthcareCancer Genomics and Diagnostics

Cited by 188

Machine learning for genetics-based classification and treatment response prediction in cancer of unknown primary

Moon, I., LoPiccolo, J., Baca, S. C., Sholl, L. M., Kehl, K. L., Hassett, M. J., Liu, D., Schrag, D., & Gusev, A. (2023) · Nature Medicine

Cancer Diagnosis and TreatmentCancer Genomics and Diagnostics

Cited by 122

Ancestry-driven recalibration of tumor mutational burden and disparate clinical outcomes in response to immune checkpoint inhibitors

Nassar, A. H., Adib, E., Abou Alaiwi, S., El Zarif, T., Groha, S., Akl, E. W., Nuzzo, P. V., Mouhieddine, T. H., Perea-Chamblee, T., Taraszka, K., et al. (2022) · Cancer Cell

Cancer Immunotherapy and BiomarkersCancer Genomics and Diagnostics

Cited by 121

Regional Variation in Spending and Survival for Older Adults With Advanced Cancer

Brooks, G. A., Li, L., Sharma, D. B., Weeks, J. C., Hassett, M. J., Yabroff, K. R., & Schrag, D. (2013) · JNCI: Journal of the National Cancer Institute

Economic and Financial Impacts of CancerHealthcare Policy and Management

Cited by 98

Natural Language Processing to Ascertain Cancer Outcomes from Medical Oncologist Notes

Kehl, K. L., Xu, W., Lepisto, E., Elmarakeby, H., Hassett, M. J., Van Allen, E. M., Johnson, B. E., & Schrag, D. (2020) · JCO Clinical Cancer Informatics

Machine Learning in HealthcareBiomedical Text Mining and Ontologies

Cited by 90

Identification of meaningful individual-level change thresholds for worsening on the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)

Lee, M. K., Mitchell, S. A., Basch, E., Mazza, G. L., Langlais, B. T., Thanarajasingam, G., Ginos, B. F., Rogak, L., Meek, E. A., Jansen, J., et al. (2025) · Quality of Life Research

Cancer survivorship and careStatistical Methods in Clinical Trials

Cited by 8

Abstract 5721: Automated annotation for large-scale clinicogenomic models of lung cancer treatment response and overall survival

Jee, J., Fong, C., Pichotta, K., Tran, T., Luthra, A., Altoe, M., Maron, S., Shen, R., Liu, S.-Y., Waters, M., et al. (2023) · Cancer Research

Lung Cancer Treatments and MutationsRadiomics and Machine Learning in Medical Imaging

Cited by 4

Evaluating the use of web versus mobile devices for ePRO reporting and severe symptom responses at 6 cancer centers.

Cronin, C., Tramontano, A., Schrag, D., Wong, S. L., Osarogiagbon, R. U., Hazard-Jenkins, H. W., Dizon, D. S., Bian, J. J., & Hassett, M. J. (2022) · Journal of Clinical Oncology

Cancer survivorship and careMobile Health and mHealth Applications

Cited by 1